Skip to content

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

  1. Home/
  2. News/
  3. Innovation/
  4. About the Johnson & Johnson Women in STEM²D Scholars Award Program

About the Johnson & Johnson Women in STEM²D Scholars Award Program

WiSTEM microscope

The Johnson & Johnson Scholars Award Program aims to fuel the development of female STEM2D leaders and feed the STEM2D talent pipeline by awarding and sponsoring women at critical points in their research careers, in each of the STEM2D disciplines: Science, Technology, Engineering, Math, Manufacturing and Design.

The awards will fund one woman per discipline who has completed her advanced degree, who is working as an assistant professor or global equivalent and who is not yet tenured at an accredited university or design institution. The goal is to fuel the research passion of the awarded women and inspire career paths in their respective STEM2D fields.

By offering these awards, Johnson & Johnson hopes to play an influential role in STEM2D breakthroughs in the future.

WiSTEM2D Scholars Award

The Johnson & Johnson WiSTEM²D Scholars Award Program will help develop female leaders and support innovation in STEM fields.

More from Johnson & Johnson

What is a rheumatic disease?

More than 200 conditions are classified as rheumatic diseases, and they tend to affect the joints and connective tissues. Here’s what a doctor wants you to know about the different types, symptoms and risk factors—and how Johnson & Johnson is innovating new treatments.

Using your own cells to fight cancer

Cell therapy is bringing the world one step closer to eliminating cancer. Here’s how Johnson & Johnson has treated more than 10,000 patients and counting with this cutting-edge therapy.

What are biologics?

Biologics, a class of medications derived from living organisms, treat a range of conditions including immune-mediated diseases and cancer. Learn how Johnson & Johnson is innovating in biologics to improve treatment options for people around the world.